Manufactures and sells a variety of cigarettes, fine cut tobacco, and smokeless tobacco products. Now — the numbers.
This is an established company with proven profits.
No real growth.
The gap is $11.6B. In times of high interest rates, a gap like that can squeeze a company.
The market pays 9.1× for every dollar of annual profit — cheap, which is either an opportunity or a warning.
No analyst target is on record for this company.
The stock trades 29% below its peak. The market has trimmed its expectations for the company.
It pays out $2.20 per share each year — regular cash for whoever holds the stock.
Over the last 4 years, sales fell about 0% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.
Since the drop from its peak, buyer appetite hasn’t come back.
Against everything we grade, IMBBF lands near the bottom. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: IMBBF does earn real profits — but on our report card it still sits behind its class. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.
Not covered, because the filings we hold do not carry it: the revenue breakdown.